Xavier Llor, Erin Wysong Hofstatter

Cancer Genetics: A Clinical Approach

• Broschiertes Buch

Produktbeschreibung

Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. The ultimate guide to caring for and communicating with patients suffering with hereditary cancer syndromes Providing the essential tools needed to understand clinical cancer genetics, Cancer Genetics: A Clinical Approach builds your mastery of differential diagnosis formulation, all the available genetic testing options at your disposal, interpreting results logically and accurately, and educating patients and their families about effective cancer prevention methods. This unparalleled resource walks you through the process of effectively and thoughtfully counseling patients-from pre-test counseling and relaying test results to navigating the legal implications of hereditary conditions and coping with the resulting psychological challenges. Cancer Genetics: A Clinical Approach is ideal for both specialized cancer genetics clinics or any healthcare professional seeking to improve their skills in identifying patients with possible hereditary cancer syndromes and recognizing which ones should be referred to a high-risk/clinical genetics specialty program.

Produktdetails

• Verlag: McGraw-Hill Education
• Seitenzahl: 480
• Erscheinungstermin: 18. November 2021
• Englisch
• Abmessung: 194mm x 242mm x 28mm
• Gewicht: 1116g
• ISBN-13: 9781260440270
• ISBN-10: 1260440273
• Artikelnr.: 59993795

Autorenporträt

Xavier Llor, MD, PhD, is Associate Professor of Medicine (Digestive Diseases); Medical Director, Colorectal Cancer Prevention Program; Co-Director, Cancer Genetics and Prevention Program, Medical Oncology, at the Yale Cancer Center. He has made seminal contributions to the field of Lynch syndrome diagnosis, as well as in the definition of other non-polyposis syndromic colorectal cancer cases. His most recent work is helping doctors and researchers understand the biological differences that contribute to disparities in colorectal cancer. Erin Wysong Hofstatter, MD, is Associate Professor and Co-Director, Cancer Genetics and Prevention Program, Medical Oncology, Yale Cancer Center. She serves as a breast medical oncologist at the Breast Center at Smilow Cancer Hospital, where she treats patients with breast cancer. Dr. Hofstatter also serves as the Co-Director of the Smilow Cancer Genetics and Prevention Program/Director of the Breast Cancer Prevention Clinic, where she cares for patients who may be at increased risk of breast cancer due to a hereditary/genetic predisposition, a strong family history, or breast atypia.

Inhaltsangabe

TABLE OF CONTENTS
Introduction
CHAPTER I: Clinical Cancer Genetics
CHAPTER 2: Risk assessment in the PCP office: identification of patients
for referral
CHAPTER 3: Principals of Cancer Risk Assessment and Genetic Counseling
CHAPTER 4: Laboratory Methods in Cancer Genetic Testing
CHAPTER 5: Understanding tumor and genetic test results. Somatic Tumor
Testing and Incidental Germline Findings
CHAPTER 6: Risk Assessment and Clinical Management- Breast Cancer
-Disease-specific Cancer Epidemiology
-Disease-specific Approach to Risk Assessment, Counseling and Testing
-Hereditary Cancer Syndromes
-Clinical Management of Patients at Increased Risk
CHAPTER 7: Risk Assessment and Clinical Management- ColonCancer, Polyposis
CHAPTER 8: Risk Assessment and Clinical Management - Colon Cancer,
Non-Polyposis
CHAPTER 9: Risk Assessment and Clinical Management - Ovarian Cancer
CHAPTER 10: Risk Assessment and Clinical Management -Uterine Cancer
CHAPTER 11: Risk Assessment and Clinical Management -Pancreatic Cancer
CHAPTER 12: Risk Assessment and Clinical Management -Urinary Tract Cancer
CHAPTER 13: Risk Assessment and Clinical Management -Stomach Cancer
CHAPTER 14: Risk Assessment and Clinical Management - Endocrine Cancer
CHAPTER 15: Risk Assessment and Clinical Management - Skin Cancer
CHAPTER 16: Risk Assessment and Clinical Management - Pediatric and Other
Cancers
CHAPTER 17: Psychological, Ethical, and Legal Issues inCancer Risk
Assessment and Genetic Testing
CHAPTER 18: Talking to kids of cancer risk
CHAPTER 19: Future challenges and opportunities in cancer genetics